Matthew Zuga
Overview
Matthew Zuga received an average of $1M in total compensation, including $399K in salary, at Acumen Pharmaceuticals from 2021 to 2023.
Source: SEC filings on April 22, 2024, April 27, 2023, and April 27, 2022.
Related executives
We found three more executives who work or worked at Acumen Pharmaceuticals.